Tobacco companies BAT and Imperial slip on Trump easing cannabis laws

FTSE 100-listed tobacco giants British American Tobacco PLC (LSE:BATS) and Imperial Brands PLC (LSE:IMB) slumped as North American cannabis stocks surged on reports that President Trump is considering easing restrictions on the sale of marijuana.  Trump may sign an executive order to reschedule marijuana at the federal level, potentially moving it from highly restricted Schedule I (which also includes drugs like heroin, LSD and ecstasy) to Schedule III, where drugs are recognized to have medical use and a moderate to low potential for abuse.

Proactive Investors • Dec 12, 2025

British American Tobacco: Deleveraging, Buybacks, 5% Yield Fuel Next Leg Of The Bull Run

I anchor my bull thesis on British American Tobacco's third FY25 revenue upgrade, 95% cash-flow conversion, planned 2.0–2.5x leverage, and an increased £1.3bn 2026 buyback despite deleveraging. H1 2025 US revenue grew 3.7% despite a 7.6% combustibles volume decline, with pricing lifting combustibles revenue 11.4% and Velo Plus lifting the modern oral segment. I also see vapour and heated products as headwinds. Vuse revenue faces a high-single-digit FY25 decline, glo revenue is flat, and heated share is down 1.2 ppt.

Seeking Alpha • Dec 12, 2025

UVV or BTI: Which Is the Better Value Stock Right Now?

Investors with an interest in Tobacco stocks have likely encountered both Universal Corp. (UVV) and British American Tobacco (BTI). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Dec 11, 2025

Tobacco industry links with EU officials underreported, campaigners say

European Union officials have held multiple, undisclosed meetings with the tobacco industry, which uses political connections to try to influence policy in the bloc and beyond, a report by campaign groups published on Wednesday found.

Reuters • Dec 10, 2025

British American Tobacco unveils new buyback as US law enforcement helps vape sales

British American Tobacco PLC (LSE:BATS) announced an increased share buy-back of £1.3 billion for next year as it backed its outlook for this year and next. The cigarette and vape maker now expects around 2% growth in both revenue and adjusted profit from operations for the current year, having suggested in the summer that for 1-2% revenue growth this year would enable profit to increase 1.5-2.5%.

Proactive Investors • Dec 9, 2025

BAT slips lower as guidance lacks spark

British American Tobacco PLC (LSE:BATS) fell 4% to 4,146p on Tuesday, leaving it at the bottom of the FTSE 100 after its latest trading update offered what one analyst described as “nearly there, but not quite”. The company said trading for 2025 was “in line”, though expectations were already modest.

Proactive Investors • Dec 9, 2025

British American Tobacco p.l.c. (BTI) Discusses Full Year Pre-Close Update With Focus on New Category Growth and US Market Momentum Transcript

British American Tobacco p.l.c. (BTI) Discusses Full Year Pre-Close Update With Focus on New Category Growth and US Market Momentum Transcript

Seeking Alpha • Dec 9, 2025

Is Your Retirement Income Enough? How I Leveled Up Mine With Covered Call ETFs

Yield for traditional income sources have started to compress. For income-oriented investors, who seek to build a reliable passive income machine it causes a real headache. To hit a certain target income figure, investors have to assume either higher risks, extend time horizon or save/invest more capital.

Seeking Alpha • Dec 3, 2025

3 Dividend Stocks Wall Street is Piling Into Before 2026

There is an apparent shift in how Wall Street views the stock market, as retail investors are increasingly doubting the AI rally.

24/7 Wall Street • Dec 2, 2025

UVV vs. BTI: Which Stock Is the Better Value Option?

Investors looking for stocks in the Tobacco sector might want to consider either Universal Corp. (UVV) or British American Tobacco (BTI). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Nov 25, 2025